Inhaled treatment and immune-modulation options for respiratory infections show distinct promise yet remain under-explored
John LaCava Answered Oct 15, 2022
The Rockefeller University
Here is a publication on that subject: https://www.science.org/doi/10.1126/sciadv.abh0319
Peter Fridy Answered Oct 15, 2022
The Rockefeller University
Yes, this is absolutely being explored. Nanobodies are great candidates for intranasal treatment as they are more stable to nebulization than standard antibodies.
My answer
Write your answer...
References (optional)
Add more